home
Registration Registration REGISTER FOR THE CONFERENCE Apply to Exhibit Apply to Exhibit APPLICATION FOR EXHIBITION Sponsorship Sponsorship SPONSORSHIP APPLICATION

Nuclear Energy Highlights

View more >

Fusion

View more >
Naju City, Korea Proposes Construction of National Fusion Energy Center

Naju City, Korea Proposes Construction of National Fusion Energy Center

2026-08-22

Naju City, Korea recently proposed the concept of building a national-level fusion energy center, planning to use the locally planned artificial sun research facility as a foundation to connect the entire process of fusion energy from basic research, demonstration and validation, to power generation and industrialization. On August 21, Naju City Mayor Yoon Byung-tae visited the Korea Institute of Fusion Energy (KFE) and met with its President Oh Young-kuk. Yoon proposed that Naju City would strive to host the fusion demonstration reactor (DEMO) linked to the artificial sun research facility, while promoting the construction of a government-led comprehensive fusion energy research base and industrial cluster, and applying for the designation of a specialized fusion energy...

More >
ITER vacuum vessel assembly in France progresses steadily, with five European sectors at different critical stages

ITER vacuum vessel assembly in France progresses steadily, with five European sectors at different critical stages

2026-08-21

The vacuum vessel assembly work for the International Thermonuclear Experimental Reactor (ITER) project in southern France is progressing steadily. As the core component of the ITER tokamak device, the vacuum vessel will contain the plasma confined by superconducting magnets, serving as the critical space where fusion reactions occur. This stainless steel ring-shaped structure weighs approximately 5,200 tonnes in total, measures 19.4 meters in diameter, and consists of nine sectors, five of which are manufactured by Europe. The European Fusion for Energy organization (F4E), together with the AMW consortium comprising Ansaldo Nucleare, Westinghouse Electric Italy, and Walter Tosto Company, is responsible for the related manufacturing work.

More >
Progress in Tritium Containment and Radiation Protection Materials Research at the Institute of Plasma Physics, Chinese Academy of Sciences

Progress in Tritium Containment and Radiation Protection Materials Research at the Institute of Plasma Physics, Chinese Academy of Sciences

2026-08-21

Recently, Associate Researcher Huo Zhipeng of the Fusion Reactor Blanket and Safety Research Center at the Institute of Plasma Physics, Chinese Academy of Sciences, together with his supervised master's students Zhang Jie and Chen Zuoyang, developed a class of flexible PbWO4-B4C reinforced silicone rubber composites with dual functions of tritium safety containment and nuclear radiation protection. The related research results were published in Journal of Materials Research and Technology. Future fusion facilities require comprehensive performance from radiation protection materials in tritium safety containment systems, including airtight sealing, flexibility for easy assembly and disassembly, and radiation shielding capability, for penetration hole sealing, post-maintenance, and high-flux neutron and γ-ray radiation protection. The research...

More >
German SIBAF Project Receives €9.7 Million to Support Fusion Materials Research

German SIBAF Project Receives €9.7 Million to Support Fusion Materials Research

2026-08-21

On August 20, 2026, with funding from the German Federal Ministry of Research, Technology and Space (BMFTR), the SIBAF project will launch the construction of an accelerator infrastructure for fusion materials research. The project, whose full name is Superconducting Ion Accelerator as a Foundational Technology for Fusion Research, will receive €9.7 million over three years, of which €8.1 million is allocated to the GSI Helmholtz Centre for Heavy Ion Research (GSI) and its Facility for Antiproton and Ion Research (FAIR), currently under construction. Goethe University Frankfurt will also participate in the project. SIBAF is part of the funding program "Fusion Foundational Technologies — Toward the Fusion Power Plant." Project objectives...

More >
Russia Plans to Build New Tokamak Device Using Reactor Technologies

Russia Plans to Build New Tokamak Device Using Reactor Technologies

2026-08-21

Alexey Likhachev, Director General of Rosatom, recently stated at a nuclear energy development conference that Rosatom is collaborating with the Kurchatov National Research Centre to build a new tokamak device using reactor technologies. Likhachev said that fusion energy technology is one of the key directions for Russia's nuclear energy development. Currently, the European Union, the United States, the United Kingdom, and China are all advancing related projects, and technological competition in the field of controlled thermonuclear fusion continues to intensify. Russia hopes to use this project to maintain its technological leadership in this knowledge-intensive nuclear energy sector.

More >
U.S. SYNOPTICS Produces Large-Size Yb:YLF Crystal for Inertial Confinement Fusion Laser Systems

U.S. SYNOPTICS Produces Large-Size Yb:YLF Crystal for Inertial Confinement Fusion Laser Systems

2026-08-21

On August 19, SYNOPTICS, a subsidiary of Northrop Grumman, announced that it had successfully grown and harvested a large-size ytterbium-doped yttrium lithium fluoride crystal, namely a Yb:YLF crystal ingot. The crystal measures approximately 127 millimeters at its widest point, with a diameter three times the industry standard. SYNOPTICS stated that as laser engineering continues to expand toward higher efficiency and higher power, the demand for gain media with larger apertures and larger dimensions continues to grow. The Yb:YLF crystal produced this time is approximately 20% larger than the largest crystal the company had previously grown, and approximately 50% larger than the company's conventional product size. Kevin Stevens, General Manager of SYNOPTICS, stated that yttrium lithium fluoride is a commonly used host material for laser-active rare-earth ions, and scaling up the growth of YLF crystals will help laser engineers continue to raise the upper limit of achievable laser output power. He said that such materials are of significant importance for applications including directed energy, inertial confinement fusion, and industrial laser systems. Stevens also stated that Yb:YLF crystals can be used in applications requiring reduced thermal lensing effects and enhanced pulsed energy storage capability, while also leveraging their natural birefringent host to achieve polarization characteristics. According to information recently released by SYNOPTICS, some of the crystals will be used in the high-energy laser system at the German Electron Synchrotron Research Center (DESY) to support its inertial confinement fusion energy research. The company is currently studying the feasibility of further scaling up the size of Yb:YLF crystals, and plans to extend the relevant processes to other rare-earth-ion-doped YLF crystals, including holmium, thulium, and neodymium doping systems.

More >

Nuclear Application

View more >

Indiana University Health Establishes Center of Excellence in Theranostics to Advance Precision Targeted Cancer Therapy

Indiana University Health is establishing a new Center of Excellence in Theranostics, planning to provide cancer patients with more personalized diagnostic and treatment services through theranostic technologies. The project combines advanced medical imaging, precision diagnostics, and image-guided targeted therapy, aiming to enhance access to relevant medical services for patients in Indiana. Partial funding comes from a $20 million donor contribution, with Indiana University providing matching funds to bring total donations to $40 million. According to Indiana University, theranostics is a technological approach that integrates diagnosis and treatment. Clinically, advanced imaging techniques are first used...

2026-08-23

Global PET Market Expected to Reach $2.81 Billion by 2035, PET-CT Remains Dominant

A market research report shows that the global Positron Emission Tomography (PET) market size is expected to increase from $1.86 billion in 2025 to $2.81 billion by 2035, with a compound annual growth rate (CAGR) of 4.26% from 2026 to 2035. Increased demand for cancer diagnosis, expanded application of hybrid imaging technologies such as PET-CT and PET-MRI, and continued development of molecular imaging technologies are considered major factors driving market growth. The report notes that PET scans are being increasingly used in scenarios such as cancer detection and treatment evaluation, cardiac disease assessment, and diagnosis of neurological and psychiatric disorders. Meanwhile, population aging, rising healthcare expenditures, and growing demand for early screening are also driving...

2026-08-23

Hengyang New Radiopharmaceutical Isotope and Drug Industrialization Project Officially Launched

On August 22, the groundbreaking ceremony for the Hengyang New Radiopharmaceutical Isotope and Drug Industrialization Project was held in Hengyang, Hunan Province. Officials from Hengyang City and Zhuhui District, representatives from relevant colleges of the University of South China, investment institutions, and relevant personnel from New Radiopharmaceutical Medical attended the event. Cai Jiming, Chairman and President of New Radiopharmaceutical Medical, stated at the ceremony that the project's landing in Hengyang represents an important strategic layout for the company's nuclear medicine business. From contract signing to construction commencement, the project has received support from local governments, partners, and relevant organizations. The company will leverage this project as an opportunity to continue advancing the transformation of innovative achievements in the fields of medical isotopes and radiopharmaceuticals. Wang Jing, Deputy Mayor of Hengyang City, stated that Hengyang...

2026-08-22

Cubresa Brain PET Scanner Receives FDA 510(k) Clearance, Integrates with Existing PET/MR Systems

Molecular imaging technology company Cubresa Inc. announced on August 20 that its Cubresa BrainPET™ scanner has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). According to the company, the Cubresa BrainPET™ is a positron emission tomography (PET) device specifically designed for brain imaging and can be integrated into existing Siemens Biograph mMR MR/PET systems. The device enables healthcare institutions to perform simultaneous PET/MR brain imaging on existing MRI infrastructure, capturing molecular and anatomical information without the need to purchase a separate whole-body hybrid imaging system. Cubresa founder and CEO James ...

2026-08-22

Portal Inspection and Screening System Tested at Chernyshevskoye Border Crossing on Russia-Lithuania Border

On August 20, the customs authorities of the Kaliningrad region of Russia, together with the equipment manufacturer, conducted functional tests of the portal inspection and screening system at the Chernyshevskoye border crossing on the Russia-Lithuania border, focusing on verifying equipment operational status and vehicle inspection capabilities. According to reports, among all Russian border crossings in the Kaliningrad region, only the Chernyshevskoye international road crossing is currently equipped with portal inspection and screening devices. A total of two systems have been installed at this crossing, used respectively for inspecting vehicles entering Russia and those departing, with both units installed and put into operation in December 2025. The inspection and demonstration were carried out with the participation of government regulatory authorities and supplier representatives. The relevant equipment is planned to be...

2026-08-22

South Korea's Asan Medical Center Develops AI-Based Radiopharmaceutical Therapy Platform with U.S. Institutions

The research team at Asan Medical Center in Seoul announced on the 21st that it has recently been selected for the "2026 Korea-U.S. Innovative Outcomes R&D New Support Project" organized by the Ministry of Health and Welfare, and will collaborate with U.S. research institutions to develop an artificial intelligence-based radiopharmaceutical therapy platform aimed at exploring new treatment strategies for solid tumors that respond poorly to conventional therapies. The team is composed of professors including Myung Seung-jae from the Department of Gastroenterology, Oh Seung-jun from the Department of Nuclear Medicine, Ryu Chang-hoon from the Department of Oncology, Jung Byung-kwan from the Department of Pathology, and Son Byung-ho from the Department of Breast Surgery at Asan Medical Center. The project will combine Asan Medical Center's large-scale clinical and pathological data, Emory University's AI-based digital pathology analysis technology, and Case Western Reserve University and University Hospitals Cleveland Medical Center's pathological and clinical research capabilities.

2026-08-22